# Treatment for Knee Osteoarthritis With Injections of BMC at the Bone-cartilage Interface. Pilot Study

> **NCT03110666** · PHASE4 · COMPLETED · sponsor: **Istituto Ortopedico Rizzoli** · enrollment: 17 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** Injection of autologous concentrated bone marrow aspirate

## Key facts

- **NCT ID:** NCT03110666
- **Lead sponsor:** Istituto Ortopedico Rizzoli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-14
- **Primary completion:** 2018-11-25
- **Final completion:** 2022-05
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110666, "Treatment for Knee Osteoarthritis With Injections of BMC at the Bone-cartilage Interface. Pilot Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03110666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*